Interview - Daniella Gilboa, AIVF

AiVF is an innovative startup at the intersection of healthcare and artificial intelligence, founded by Daniela Gilboa, a trained embryologist. The company’s mission is to improve fertility treatments by leveraging data and AI, with the goal of helping more couples become parents. Founded in 2018, AiVF has quickly established itself as a pioneer in the digital transformation of assisted reproductive technology clinics.The technology developed by AiVF enables the centralization and analysis of data from fertility clinics via a single platform. It automates certain key processes and helps doctors and embryologists make more reliable decisions through analyses based on objective data, rather than subjective judgments. The goal is not to replace humans, but to enhance their capabilities through artificial intelligence. The company already operates internationally, with partner clinics in Europe, the United States, Latin America, and Asia. It has contributed to several thousand pregnancies and the birth of many children, providing concrete proof of its technology’s impact. In a context where demand for in vitro fertilization is skyrocketing worldwide, AiVF plays a key role in helping clinics become more efficient and treat more patients. Private equity has enabled AiVF to accelerate its development by providing both capital and strategic guidance. Investors play an active role as partners, helping to structure growth, strengthen strategy, and position the company as a market leader. This concept of “smart money” is essential for a rapidly expanding deep-tech startup. In the long term, AiVF is part of a major trend: the integration of AI into medicine. The company helps make healthcare more precise, accessible, and transparent, while addressing a major societal challenge related to fertility and demographics.